相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series
Tomiyuki Sugi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis A Randomized Clinical Trial
Margitta Worm et al.
JAMA DERMATOLOGY (2020)
Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses
Vien Phan et al.
BLOOD ADVANCES (2020)
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center
Patrick Yau et al.
LEUKEMIA & LYMPHOMA (2019)
Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma
Kevin Barley et al.
LEUKEMIA & LYMPHOMA (2016)
Multiple Myeloma Patients with Lenalidomide-Associated Skin Rash Have a Favorable Prognosis
Ayumi Kojima et al.
BLOOD (2016)
Practical Management of Lenalidomide-Related Rash
Sara M. Tinsley et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma
Min Jung Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Risk of Rash Associated With Lenalidomide in Cancer Patients: A Systematic Review of the Literature and Meta-analysis
Beatrice Nardone et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth
Sungyoul Hong et al.
CANCER RESEARCH (2008)